Make Your Bid to Support The Leukemia & Lymphoma Society in it's mission to create a world withouth blood cancer!
LLS-funded research has led to the discovery and development of lifesaving therapies, including targeted therapies that selectively kill cancer cells and immunotherapies that help a patient's immune system destroy cancer cells.
Since 1954, LLS has invested $1 billion in blood cancer research.
Some therapies that were first approved for blood cancer patients are now helping patients with different types of cancers adn other serious diseases.